Exploring ferroptosis and miRNAs: implications for cancer modulation and therapy

Mobarakeh Ajam-Hosseini1, Sadegh Babashah2

  • 1Department of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares University, P.O. Box: 14115-154, Tehran, Iran.

PubMed

Insights

Ferroptosis, a cell death linked to cancer, is regulated by microRNAs (miRNAs). Exosomal miRNAs show promise as biomarkers and therapeutic targets for managing ferroptosis in cancer pathology.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Ferroptosis is an iron-dependent cell death pathway involving lipid ROS accumulation and mitochondrial changes.
  • Ferroptosis is implicated in various diseases, particularly cancer, driving research into therapeutic strategies.
  • MicroRNAs (miRNAs) are key regulators of ferroptosis, influencing genes in iron metabolism and lipid peroxidation.

Purpose of the Study:

  • To review the role of miRNAs, especially exosomal miRNAs, in ferroptosis.
  • To explore the implications of exosomal miRNAs in cancer pathology.
  • To provide insights into potential therapeutic approaches targeting miRNA-mediated ferroptosis.

Main Methods:

  • Literature review of studies on miRNAs, exosomal miRNAs, and ferroptosis.
  • Analysis of molecular mechanisms underlying miRNA regulation of ferroptosis.
  • Examination of exosomal miRNA functions as biomarkers and therapeutic agents.

Main Results:

  • Exosomal miRNAs act as messengers, delivering regulatory molecules to target cells.
  • miRNAs modulate ferroptosis by affecting critical genes in iron metabolism and lipid peroxidation pathways.
  • Exosomal miRNAs exhibit dynamic expression patterns, making them potential cancer biomarkers.

Conclusions:

  • miRNAs, particularly exosomal miRNAs, play a significant role in ferroptosis.
  • Exosomal miRNAs offer potential as biomarkers for cancer diagnosis and prognosis.
  • Targeting exosomal miRNAs presents a promising avenue for novel cancer therapeutic strategies.